tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nektar management to meet with Piper Sandler
PremiumThe FlyNektar management to meet with Piper Sandler
1M ago
Sanofi’s ‘disappointing’ atopic dermatitis data sends Nektar higher
Premium
The Fly
Sanofi’s ‘disappointing’ atopic dermatitis data sends Nektar higher
1M ago
Piper says competitor AD data reinforces Nektar’s REZPEG differentiated profile
Premium
The Fly
Piper says competitor AD data reinforces Nektar’s REZPEG differentiated profile
1M ago
Buy Rating for Nektar Therapeutics: Upcoming Catalysts and Strong Financial Performance
PremiumRatingsBuy Rating for Nektar Therapeutics: Upcoming Catalysts and Strong Financial Performance
2M ago
Cautious Hold Rating on Nektar Therapeutics Amid Promising Yet Uncertain Clinical Developments
Premium
Ratings
Cautious Hold Rating on Nektar Therapeutics Amid Promising Yet Uncertain Clinical Developments
2M ago
Nektar Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Nektar Therapeutics Reports Q2 2025 Financial Results
2M ago
Nektar call volume above normal and directionally bullish
PremiumThe FlyNektar call volume above normal and directionally bullish
3M ago
Nektar price target raised to $85 from $60 at B. Riley
Premium
The Fly
Nektar price target raised to $85 from $60 at B. Riley
3M ago
Nektar Therapeutics Announces Public Offering of Shares
Premium
Company Announcements
Nektar Therapeutics Announces Public Offering of Shares
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100